Lengthy timelines and high costs remain major challenges in pharmaceutical R&D. As pressure grows to bring medicines to patients faster, laboratories must find smarter ways to accelerate their ...

The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...

Join Ryan Duggan (AbbVie) and David Leclerc (President, GLIIFCA) for a balanced discussion on how automation is reshaping modern flow cytometryworkflows. Ryan will share insights from AbbVie’s first ...

The design of the modern R&D lab may be due for a rethink. Artificial intelligence and automation are reshaping how science gets done, yet many of the physical spaces where research happens were built ...

Insilico Medicine ( “Insilico”, HKEX:3696 ), a clinical-stage, generative AI–driven drug discovery company, today announced LabClaw, its next-generation intelligent laboratory operating system. As the ...

Biosero, a BICO company and developer of integrated laboratory automation solutions, signed a master service agreement with a global pharma company in August 2025 and has now received the first ...

After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first collaboration with a major cell therapy developer. Multiply Labs and Legend ...

The pharmaceutical industry is increasingly focused on the concept of acceleration. Adaptive clinical trial designs and an expanding set of expedited regulatory pathways have been introduced to ...

Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping the operation overseas. The Big Pharma is selling a majority of the Life Sciences Studio ...